“…There have been a number of studies that demonstrate the beneficial neuroprotective and neuroreparative effects of M2 switching [68][69][70][71]. These studies have focused on the importance of various M2 markers such as IL-4 [72,73], IL-10 [72,74,75], IL-1RA [76], TGF-β [77,78], CD206 [72,79], arginase 1 [79,80], granulocyte macrophage colony-stimulating factor [72], insulin-like growth factor 1 [81,82], and peroxisome proliferator-activated receptor-γ [70,71,83]. Even though our understanding of the role of these individual factors have become more insightful, it is very difficult to achieve beneficial neuroprotective effects by modulating just one of these factors.…”